Podcast: Professor Carolyn Lam states that dapagliflozin appears to meet the three major aims of HFrEF treatment, ie, reduced mortality, reduced hospitalization, and improved quality of life.

26 Nov 2019
Podcast: Professor Carolyn Lam states that dapagliflozin appears to meet the three major aims of HFrEF treatment, ie, reduced mortality, reduced hospitalization, and improved quality of life.
Editor's Recommendations